Literature DB >> 20140318

[Depression in HIV infection: prevalence, risk factors and management].

Claudia Wolff L1, Rubén Alvarado M, Marcelo Wolff R.   

Abstract

Depression is one of the main psychiatric co-morbidities in HIV infection, presenting with a significantly higher prevalence than in the general population (around 35%). Its presence has been associated with poor quality of life, HIV disease progression and poor adherence to antiretroviral therapy. Although antidepressive treatment has demonstrated effectiveness on the management of depressive symptoms, improvement of clinical and laboratory parameters, and enhancement of antiretroviral adherence, depression is frequently under diagnosed and under treated in these patients. We analyzed the main international findings on depression prevalence, risk factors, con-sequences and management in people with HIV disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20140318     DOI: /S0716-10182010000100011

Source DB:  PubMed          Journal:  Rev Chilena Infectol        ISSN: 0716-1018            Impact factor:   0.520


  9 in total

1.  Suicide risk and prevalence of major depressive disorder (MDD) among individuals infected with HIV-1 subtype C versus B in Southern Brazil.

Authors:  Sergio Monteiro de Almeida; Francisco Jaime Barbosa; Rujvi Kamat; Ana Paula de Pereira; Sonia Mara Raboni; Indianara Rotta; Clea Elisa Ribeiro; Mariana Cherner; Ronald J Ellis; Joseph Hampton Atkinson
Journal:  J Neurovirol       Date:  2016-07-18       Impact factor: 2.643

2.  Depression and Apathy Among People Living with HIV: Implications for Treatment of HIV Associated Neurocognitive Disorders.

Authors:  Vaughn E Bryant; Nicole E Whitehead; Larry E Burrell; Vonetta M Dotson; Robert L Cook; Paul Malloy; Kathryn Devlin; Ronald A Cohen
Journal:  AIDS Behav       Date:  2015-08

Review 3.  Depression in HIV infected patients: a review.

Authors:  Maria Giulia Nanni; Rosangela Caruso; Alex J Mitchell; Elena Meggiolaro; Luigi Grassi
Journal:  Curr Psychiatry Rep       Date:  2015-01       Impact factor: 5.285

Review 4.  Human immunodeficiency virus-associated depression: contributions of immuno-inflammatory, monoaminergic, neurodegenerative, and neurotrophic pathways.

Authors:  F B Del Guerra; J L I Fonseca; V M Figueiredo; E B Ziff; E Castelon Konkiewitz
Journal:  J Neurovirol       Date:  2013-07-19       Impact factor: 2.643

Review 5.  Meta-Analysis of the COMT Val158Met Polymorphism in Major Depressive Disorder: Effect of Ethnicity.

Authors:  Maiqiu Wang; Yunlong Ma; Wenji Yuan; Kunkai Su; Ming D Li
Journal:  J Neuroimmune Pharmacol       Date:  2016-01-23       Impact factor: 4.147

6.  Depression and adherence to antiretroviral treatment in HIV-positive men in São Paulo, the largest city in South America: Social and psychological implications.

Authors:  Ricardo Pereira de Moraes; Jorge Casseb
Journal:  Clinics (Sao Paulo)       Date:  2017-12       Impact factor: 2.365

Review 7.  The potential role of vagus-nerve stimulation in the treatment of HIV-associated depression: a review of literature.

Authors:  William C Nicholson; Mirjam-Colette Kempf; Linda Moneyham; David E Vance
Journal:  Neuropsychiatr Dis Treat       Date:  2017-06-28       Impact factor: 2.570

8.  Neuropsychological functioning and cognitive reserve in newly HIV diagnosed antiretroviral-naïve South African adults from peri-urban and informal settlements.

Authors:  Kalpesh Narsi; Andrew Tomita; Suvira Ramlall
Journal:  PLoS One       Date:  2021-12-07       Impact factor: 3.240

9.  Aging with HIV: an overview of an urban cohort in Rio de Janeiro (Brazil) across decades of life.

Authors:  Thiago Silva Torres; Sandra Wagner Cardoso; Luciane de Souza Velasque; Luana Monteiro Spindola Marins; Marília Santini de Oliveira; Valdilea Gonçalves Veloso; Beatriz Grinsztejn
Journal:  Braz J Infect Dis       Date:  2013-04-18       Impact factor: 3.257

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.